Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date
Simulations Plus (Nasdaq: SLP) has announced its upcoming fourth quarter and fiscal 2024 financial results release, scheduled for Wednesday, October 23, 2024, after the market close. The company will host a conference call and live webcast on the same day at 5:00 p.m. Eastern Time to discuss the results.
Interested parties, including investment professionals and shareholders, can join the webcast by registering online. Alternatively, participants can dial in using 1-877-451-6152 (domestic) or 1-201-389-0879 (international) numbers. A 'Call me' link is also available for those requesting a return call.
The webcast will be accessible on the Simulations Plus investor relations page, where it will remain available for replay approximately one hour after the call concludes.
Simulations Plus (Nasdaq: SLP) ha annunciato la pubblicazione dei risultati finanziari per il quarto trimestre e l'anno fiscale 2024, prevista per mercoledì 23 ottobre 2024, dopo la chiusura del mercato. L'azienda organizzerà una teleconferenza e una diretta web lo stesso giorno alle 17:00 ora orientale per discutere i risultati.
Le parti interessate, inclusi i professionisti degli investimenti e gli azionisti, possono partecipare alla diretta registrandosi online. In alternativa, i partecipanti possono chiamare il numero 1-877-451-6152 (per chiamate nazionali) o 1-201-389-0879 (per chiamate internazionali). È anche disponibile un link 'Call me' per coloro che richiedono una richiamata.
La diretta sarà accessibile sulla pagina delle relazioni con gli investitori di Simulations Plus, dove rimarrà disponibile per la visione in replay circa un'ora dopo la conclusione della chiamata.
Simulations Plus (Nasdaq: SLP) ha anunciado la próxima publicación de sus resultados financieros para el cuarto trimestre y el año fiscal 2024, programada para miércoles 23 de octubre de 2024, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica y una transmisión en vivo el mismo día a las 5:00 p.m. Hora del Este para discutir los resultados.
Las partes interesadas, incluidos los profesionales de la inversión y los accionistas, pueden unirse a la transmisión registrándose en línea. Alternativamente, los participantes pueden marcar los números 1-877-451-6152 (nacional) o 1-201-389-0879 (internacional). También hay un enlace 'Call me' disponible para aquellos que soliciten una devolución de llamada.
La transmisión estará disponible en la página de relaciones con los inversores de Simulations Plus, donde permanecerá disponible para su reproducción aproximadamente una hora después de que concluya la llamada.
Simulations Plus (Nasdaq: SLP)는 2024년 10월 23일 수요일 시장 종료 후 예정된 4분기 및 2024 회계연도 재무 결과 발표를 발표했습니다. 회사는 그날 미국 동부 시간 기준 오후 5시에 결과를 논의하기 위한 전화 회의와 생중계를 진행할 것입니다.
투자 전문가 및 주주를 포함한 관심 있는 당사자들은 온라인으로 등록하여 생중계에 참여할 수 있습니다. 또는 참가자는 1-877-451-6152(국내) 또는 1-201-389-0879(국제)로 전화 연결할 수 있습니다. 다시 전화를 요청하는 분들을 위한 'Call me' 링크도 제공됩니다.
생중계는 Simulations Plus 투자자 관계 페이지에서 접근 가능하며, 통화가 끝난 후 약 1시간 동안 재생할 수 있습니다.
Simulations Plus (Nasdaq: SLP) a annoncé la prochaine publication de ses résultats financiers pour le quatrième trimestre et l'exercice 2024, prévue pour mercredi 23 octobre 2024, après la fermeture du marché. L'entreprise organisera une conférence téléphonique et un webcast en direct le même jour à 17h00, heure de l'Est, pour discuter des résultats.
Les parties intéressées, y compris les professionnels de l'investissement et les actionnaires, peuvent rejoindre le webcast en s'inscrivant en ligne. Alternativement, les participants peuvent composer le 1-877-451-6152 (national) ou le 1-201-389-0879 (international). Un lien 'Call me' est également disponible pour ceux qui demandent un retour d'appel.
Le webcast sera accessible sur la page des relations investisseurs de Simulations Plus, où il restera disponible pour rediffusion environ une heure après la fin de l'appel.
Simulations Plus (Nasdaq: SLP) hat die bevorstehende Veröffentlichung der finanziellen Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024 angekündigt, die für Mittwoch, den 23. Oktober 2024, nach Börsenschluss geplant ist. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz und einen Live-Stream abhalten, um die Ergebnisse zu diskutieren.
Interessierte Parteien, einschließlich Investitionsprofis und Aktionären, können sich online registrieren, um am Webcast teilzunehmen. Alternativ können Teilnehmer die Nummer 1-877-451-6152 (inländisch) oder 1-201-389-0879 (international) anrufen. Ein 'Call me'-Link steht ebenfalls für diejenigen zur Verfügung, die einen Rückruf anfordern möchten.
Der Webcast wird auf der Investor Relations-Seite von Simulations Plus verfügbar sein, wo er etwa eine Stunde nach dem Ende des Gesprächs für eine Wiederholung zur Verfügung steht.
- None.
- None.
Conference call to be on Wednesday, October 23, 2024, at 5 p.m. EDT
Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 1-201-389-0879 (international) or by clicking on this Call me™ link to request a return call. The webcast can be accessed on the investor relations page of the Simulations Plus website at www.simulations-plus.com/investorscorporate-profile/corporate-profile/ where it will also be available for replay approximately one hour following the call.
About Simulations Plus, Inc.
With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241009166059/en/
Investor Relations Contacts:
Lisa Fortuna
Financial Profiles
310-622-8251
slp@finprofiles.com
Renee Bouche
Simulations Plus Investor Relations
661-723-7723
renee.bouche@simulations-plus.com
Source: Simulations Plus, Inc.
FAQ
When will Simulations Plus (SLP) report its Q4 and fiscal 2024 earnings?
What time is the Simulations Plus (SLP) Q4 2024 earnings conference call?
How can I access the Simulations Plus (SLP) Q4 2024 earnings call?
Where can I find the replay of Simulations Plus (SLP) Q4 2024 earnings call?
